Can BPH or prostatitis cause high PSA (Prostate-specific Antigen)?

Yes, both BPH (benign prostatic hyperplasia) and prostatitis can cause elevated PSA levels, making it important to consider these conditions alongside prostate cancer when interpreting high PSA results. Working with your doctor to evaluate symptoms and potentially repeat testing can help determine the underlying cause.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding PSA and Its Role in Prostate Health

Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. While PSA testing has become a cornerstone of prostate health screening, elevated levels don't automatically mean cancer. In fact, several benign conditions can cause your PSA to rise, with benign prostatic hyperplasia (BPH) and prostatitis being two of the most common culprits.

Understanding why these conditions affect PSA levels can help reduce anxiety about test results and guide more informed discussions with your healthcare provider. Let's explore how BPH and prostatitis influence PSA levels and what this means for your prostate health monitoring.

How BPH Affects PSA Levels

Benign prostatic hyperplasia, commonly known as BPH or enlarged prostate, affects up to 90% of men by age 80. As the prostate grows larger with age, it produces more PSA simply because there's more prostate tissue present. This increased tissue mass leads to higher baseline PSA levels even in the absence of cancer.

How Different Types of Prostatitis Affect PSA Levels

PSA elevations vary significantly by prostatitis type. Acute infections cause the highest spikes but respond quickly to treatment.
Type of ProstatitisTypical PSA RangeDuration of ElevationKey Symptoms
Acute BacterialAcute Bacterial20-50+ ng/mL4-6 weeksFever, severe pain, urinary symptoms
Chronic BacterialChronic Bacterial4-10 ng/mLMonthsRecurrent UTIs, pelvic discomfort
Chronic Pelvic PainChronic Pelvic Pain Syndrome2-8 ng/mLVariablePelvic pain, urinary issues, no infection
AsymptomaticAsymptomatic Inflammatory2-6 ng/mLOngoingNo symptoms, found incidentally

PSA elevations vary significantly by prostatitis type. Acute infections cause the highest spikes but respond quickly to treatment.

The Relationship Between Prostate Size and PSA

Research shows that PSA levels typically increase by approximately 0.3 ng/mL for every 10 grams of prostate tissue. Since prostates with BPH can grow from a normal 20-30 grams to 60-100 grams or more, this size increase alone can significantly elevate PSA readings. Men with larger prostates due to BPH often have PSA levels between 4-10 ng/mL, which overlaps with the range that raises concern for prostate cancer.

Understanding your baseline PSA levels and tracking changes over time becomes crucial when you have BPH. Regular monitoring through at-home testing can help you and your doctor distinguish between stable elevations due to BPH and concerning changes that might warrant further investigation.

PSA Density and BPH

To better interpret PSA levels in men with BPH, doctors often calculate PSA density - the PSA level divided by prostate volume. A PSA density below 0.15 ng/mL/cc generally suggests BPH rather than cancer, though this isn't definitive. This calculation helps account for the increased PSA production from a larger prostate.

Prostatitis and PSA Elevation

Prostatitis, or inflammation of the prostate, can cause dramatic PSA elevations that often exceed those seen with BPH. This condition affects men of all ages and can be acute (sudden onset) or chronic (long-lasting). The inflammatory process damages prostate cells, causing them to release more PSA into the bloodstream.

Types of Prostatitis and Their PSA Impact

Different types of prostatitis affect PSA levels differently. Understanding these variations helps explain your test results:

  • Acute bacterial prostatitis: Can cause PSA to spike above 20-30 ng/mL temporarily
  • Chronic bacterial prostatitis: Typically causes moderate elevations of 4-10 ng/mL
  • Chronic pelvic pain syndrome: May cause mild to moderate PSA elevation
  • Asymptomatic inflammatory prostatitis: Often discovered incidentally with elevated PSA

PSA Recovery After Prostatitis Treatment

One distinguishing feature of prostatitis-related PSA elevation is that levels typically decrease after appropriate treatment. With acute bacterial prostatitis, PSA levels may return to baseline within 4-6 weeks after antibiotic therapy. For chronic prostatitis, the recovery may take longer, sometimes 3-6 months. This responsiveness to treatment helps differentiate prostatitis from prostate cancer.

Distinguishing Between Benign Conditions and Cancer

While both BPH and prostatitis can elevate PSA, certain patterns and additional tests can help distinguish these benign conditions from prostate cancer. Understanding these differences empowers you to have more informed conversations with your healthcare provider about your results.

Key Differentiating Factors

Several factors help doctors differentiate between benign PSA elevations and those concerning for cancer:

  • PSA velocity: Cancer typically causes faster PSA rises (>0.75 ng/mL per year)
  • Free PSA percentage: Lower percentages (<25%) are more concerning for cancer
  • Age-specific ranges: PSA naturally increases with age, even without disease
  • Digital rectal exam findings: Cancer often presents as hard nodules, while BPH feels uniformly enlarged
  • Response to treatment: PSA from infection/inflammation decreases with treatment

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

When to Retest PSA Levels

If your PSA is elevated and you have symptoms of BPH or prostatitis, your doctor may recommend treating the condition and retesting PSA after several weeks. This approach can help avoid unnecessary biopsies while ensuring cancer isn't missed. The timing of retesting depends on your specific situation:

  • After acute prostatitis: Wait 4-6 weeks after completing antibiotics
  • With chronic prostatitis: May need 2-3 months for levels to stabilize
  • BPH treatment: PSA may decrease 30-50% after 6 months of 5-alpha reductase inhibitors
  • Recent procedures: Wait 6-8 weeks after prostate biopsy or surgery

Managing Your Prostate Health

Whether you have BPH, prostatitis, or are simply monitoring your prostate health, regular PSA testing provides valuable insights. However, a single elevated reading shouldn't cause panic. Working with your healthcare provider to understand your individual risk factors, symptoms, and PSA trends over time leads to better decision-making.

Lifestyle Factors That May Help

While you can't prevent age-related prostate changes, certain lifestyle modifications may support prostate health:

  • Maintain a healthy weight to reduce inflammation
  • Exercise regularly, particularly aerobic activities
  • Limit red meat and high-fat dairy consumption
  • Increase intake of tomatoes, cruciferous vegetables, and green tea
  • Manage stress, which may worsen prostatitis symptoms
  • Stay hydrated but avoid excessive fluids before bedtime

The Importance of Context in PSA Interpretation

PSA testing remains valuable for prostate health monitoring, but interpretation requires context. Your age, prostate size, symptoms, family history, and PSA trends all factor into understanding what your levels mean. Both BPH and prostatitis commonly cause PSA elevations that can be distinguished from cancer through careful evaluation and appropriate follow-up testing.

Remember that having BPH or prostatitis doesn't protect against prostate cancer - you can have both conditions simultaneously. This is why ongoing monitoring and open communication with your healthcare provider remain essential. By understanding how these benign conditions affect PSA, you can approach your prostate health with less anxiety and more informed decision-making.

References

  1. Roehrborn, C. G. (2008). BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU International, 101(S3), 17-21.[DOI]
  2. Nadler, R. B., et al. (1995). Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. Journal of Urology, 154(2), 407-413.[PubMed]
  3. Tchetgen, M. B., & Oesterling, J. E. (1997). The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration. Urologic Clinics of North America, 24(2), 283-291.[PubMed]
  4. Bozeman, C. B., et al. (2002). Prostate-specific antigen levels in men with chronic prostatitis. Journal of Andrology, 23(5), 688-690.[PubMed]
  5. Catalona, W. J., et al. (2011). What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation. Annals of Internal Medicine, 155(8), 543-544.[PubMed]
  6. Thompson, I. M., et al. (2004). Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. New England Journal of Medicine, 350(22), 2239-2246.[DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my PSA at home?

You can test your PSA at home with SiPhox Health's Hormone Focus Program, which includes PSA testing along with other key hormone biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is considered a normal PSA level?

Normal PSA levels vary by age. Generally, PSA under 2.5 ng/mL for men in their 40s-50s, under 3.5 ng/mL for men in their 60s, and under 4.5 ng/mL for men in their 70s are considered normal. However, individual baseline and trends matter more than single values.

How long should I wait to retest PSA after prostatitis?

After acute bacterial prostatitis, wait 4-6 weeks after completing antibiotics before retesting PSA. For chronic prostatitis, levels may take 2-3 months to stabilize. Your doctor can guide the optimal timing based on your specific situation.

Can PSA levels fluctuate day to day?

Yes, PSA can fluctuate by up to 20% from day to day. Factors like ejaculation (can raise PSA for 48 hours), vigorous exercise, and even constipation can cause temporary increases. This is why trends over time matter more than single readings.

Should I avoid any activities before PSA testing?

Yes, avoid ejaculation for 48 hours, vigorous exercise for 24 hours, and bicycle riding for 48 hours before testing. Also, ensure any prostate exam or procedure was at least one week prior to testing for most accurate results.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details